Merck Walks Away: What The Failed Acquisition Means For Revolution Medicines

Revolution Medicines faces high volatility after failed Merck takeover talks, with RVMD shares dropping 18% but still up 115% ...
TMCnet

GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures

The newly issued patent supports GRI Bio’s broader platform focused on modulating Natural Killer T (NKT) cell biology and complements the Company’s ongoing development of immune cell–targeted ...

Biogen Inc.: FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA acti ...

SEC Form F-3: A Guide for Foreign Issuers

SEC Form F-3 allows foreign private issuers to register securities with the SEC. Learn about its qualifications, uses, and ...